Adaptimmune Therapeutics PLC (ADAPY) Balance sheet

Market cap

$5.73M

P/E ratio

	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	163	88	72	55	61	152	110	147	93
Marketable securities, current	-	124	137	39	311	220	97	3	60
Total cash & short-term investments	163	213	209	94	373	371	206	150	154
Accounts receivable, net	1	0	0	-	0	1	7	1	1
Inventories	-	-	-	-	-	-	-	-	7
Total current assets	199	230	231	120	398	415	255	208	188
Property, plant and equipment, net	28	41	36	31	28	30	54	51	31
Total non-current assets	36	51	46	61	53	54	74	75	58
Total assets	235	281	277	182	451	470	329	283	246
Accounts payable	11	8	4	6	6	8	5	8	9
Total current liabilities	40	74	24	34	39	63	65	73	65
Long-term debt, non-current	-	-	-	-	-	-	-	-	50
Total non-current liabilities	28	4	5	24	71	201	183	170	170
Total liabilities	68	78	30	58	110	264	247	243	234
Common stock and paid-in capital	342	456	575	587	937	961	992	1,066	1,108
Retained earnings	-161	-232	-318	-456	-585,756,000	-743,846,000	-909,302,000	-1,023,173,000	-1,093,987,000
Stockholders' equity	166	203	247	124	341	206	82	40	12
Total debt	-	-	-	-	-	-	-	-	50
Net debt	-	-	-	-	-	-	-	-	-103
D/E ratio (%)	-	-	-	-	-	-	-	-	424
Working capital	-	-	-	-	-	-	-	-